MyHealthChecked PLC Directorate Change (1683H)
26 Juillet 2023 - 8:00AM
UK Regulatory
TIDMMHC
RNS Number : 1683H
MyHealthChecked PLC
26 July 2023
MyHealthChecked PLC
( " MyHealthChecked " or " the Company " )
Directorate Change
MyHealthChecked PLC (AIM: MHC), the consumer home-testing
healthcare company, announces that Nicholas Edwards, Chief
Financial Officer will leave the business on 31 July 2023.
Non-Executive Director Lesley Innes FCA, a qualified chartered
accountant, will take over Board responsibility for the Company's
Finance function.
Penny McCormick, Chief Executive Officer of MyHealthChecked,
said: " I would like to thank Nick for the role he has played in
the past 15 months at MyHealthChecked. In Lesley we have a highly
skilled qualified accountant with significant PLC experience who
will provide financial leadership moving forward.
"As we focus on a growth drive of our new Wellness portfolio, we
will continue to review our commercial investments alongside our
operational cost base to ensure that we retain a strong cash
position.
"We wish Nick well in his future endeavours. "
For further information contact:
MyHealthChecked PLC www.myhealthchecked.com
Penny McCormick, Chief Executive via Walbrook PR
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin / Jade Bayat
Dowgate Capital Limited (Broker) Tel: +44 (0)20 3903 7715
David Poutney / Nicholas Chambers
Walbrook PR Ltd (Media Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
& IR)
Paul McManus / Alice Woodings Mob: +44 (0)7980 541 893 / +44
(0)7407 804 654
About MyHealthChecked PLC (
https://investors.myhealthchecked.com/ )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home
rapid tests, as well as DNA, RNA and blood sample collection kits
which have been created to support customers on their journeys to
wellness. The tests are lateral-flow self-tests, whilst the sample
collection kits enable the collection of blood, urine, nasal or
mouth swab samples that are analysed in partner laboratories for a
range of biomarkers. The tests will also be made available online
and will be viable for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED
UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014
WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL)
ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A
REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO
BE IN THE PUBLIC DOMAIN.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAKZGZNVKDGFZM
(END) Dow Jones Newswires
July 26, 2023 02:00 ET (06:00 GMT)
MyHealthChecked (AQSE:MHC.GB)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
MyHealthChecked (AQSE:MHC.GB)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024
